Dr. Bridgit V. Nolan, MD

Dr. Nolan practices at HCA Florida JFK Hospital in Atlantis, Florida, part of HCA Healthcare.

Dr. Nolan's NPI, 1801117338, was assigned on June 18, 2010. Dr. Nolan graduated from SUNY Upstate Medical University in 2010. Dr. Nolan holds Florida license ME118457.

Dr. Nolan's primary practice is HCA Florida JFK Hospital, at 5301 S Congress Ave, Atlantis, FL 33462 in Palm Beach County. The practice phone is (561) 965-7300.

Dr. Nolan's primary practice is HCA Florida JFK Hospital in Atlantis, Florida, part of HCA Healthcare. The medical group on file is Palm Beach Dermatology. Dmand AI also links Dr. Nolan to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nolan practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Nolan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Nolan is board certified in dermatology by the American Board of Dermatology. Dr. Nolan is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Nolan treats.

CMS data shows 13,920 Medicare services from Dr. Nolan across 21 procedure codes in 2024, for 1,052 Medicare patients. Medicare paid $588,806 for them. Every service was in an office.

CMS counts 1,052 Medicare patients who saw Dr. Nolan in 2024. The largest group is 65 to 74, with 460 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nolan's median patient age at 73, with 51% women.

In 2024, Dr. Nolan wrote 1,235 Medicare Part D claims for 528 patients. 98% of them were for generic drugs. CMS names the drug for 1,131 of them, across 18 drugs with 11 or more claims each, at $64,178 in total drug cost. In 2023, CMS named 1,271 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nolan for performance year 2024, reported as part of a group. Dr. Nolan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,124 procedures of skin biopsy by Dr. Nolan, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Nolan, published from 2010 to 2012. 2012 was the busiest year, with 3. The most frequent topics are Dermatologic Agents, Patient Compliance and Patient Education as Topic. Dr. Nolan has published most often in Dermatol Online J. Dr. Nolan's most frequent co-authors are Steven Richard Feldman, MD, Anna Haydee Chacon, MD and Uzma Farooq, MD.

CMS Open Payments shows 244 general payments to Dr. Nolan from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,039.

Dr. Nolan graduated from SUNY Upstate Medical University in 2010.

Dr. Nolan is in network with 6 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.